Shandong Pharmaceutical Glass Co Ltd
SSE:600529
Shandong Pharmaceutical Glass Co Ltd
Operating Income
Shandong Pharmaceutical Glass Co Ltd
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
S
|
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
|
Operating Income
¥814.7m
|
CAGR 3-Years
9%
|
CAGR 5-Years
18%
|
CAGR 10-Years
17%
|
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
|
Operating Income
¥2.6B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
Autobio Diagnostics Co Ltd
SSE:603658
|
Operating Income
¥1.2B
|
CAGR 3-Years
11%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
Winner Medical Co Ltd
SZSE:300888
|
Operating Income
¥1.8B
|
CAGR 3-Years
45%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
Operating Income
¥1.8B
|
CAGR 3-Years
20%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
Autek China Inc
SZSE:300595
|
Operating Income
¥747.4m
|
CAGR 3-Years
21%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
See Also
What is Shandong Pharmaceutical Glass Co Ltd's Operating Income?
Operating Income
814.7m
CNY
Based on the financial report for Sep 30, 2023, Shandong Pharmaceutical Glass Co Ltd's Operating Income amounts to 814.7m CNY.
What is Shandong Pharmaceutical Glass Co Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
17%
Over the last year, the Operating Income growth was 21%. The average annual Operating Income growth rates for Shandong Pharmaceutical Glass Co Ltd have been 9% over the past three years , 18% over the past five years , and 17% over the past ten years .